|
JP2008521406A
(ja)
|
2004-11-24 |
2008-06-26 |
フレッド ハッチンソン キャンサー リサーチ センター |
養子免疫療法のためのｉｌ−２１の使用法および腫瘍抗原の同定法
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
US11135245B2
(en)
|
2014-11-17 |
2021-10-05 |
Adicet Bio, Inc. |
Engineered γδ T-cells
|
|
SG11201706128PA
(en)
|
2015-01-27 |
2017-08-30 |
Lava Therapeutics B V |
Single domain antibodies targeting cd1d
|
|
GB201507368D0
(en)
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
PT3307875T
(pt)
*
|
2015-06-09 |
2022-03-21 |
Lymphact Lymphocyte Activation Tech S A |
Métodos para a produção de células t tcr gamma delta+
|
|
EP4295914A3
(en)
|
2015-09-03 |
2024-04-10 |
The UAB Research Foundation |
Genetically-engineered drug resistant t cells and methods of using the same
|
|
JP7210286B2
(ja)
|
2016-05-12 |
2023-01-23 |
アディセット バイオ， インコーポレイテッド |
γδＴ細胞集団の選択的増殖方法及びその組成物
|
|
US10426796B2
(en)
*
|
2016-06-13 |
2019-10-01 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
US10456423B2
(en)
|
2016-06-13 |
2019-10-29 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
US12350349B2
(en)
|
2016-08-03 |
2025-07-08 |
Washington University |
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors
|
|
KR102032354B1
(ko)
|
2016-11-11 |
2019-10-16 |
가톨릭대학교 산학협력단 |
신규한 배양보조세포 및 이를 이용한 감마 델타 ｔ 세포의 증식 방법
|
|
JP7291396B2
(ja)
|
2016-11-22 |
2023-06-15 |
ティーシーアール２ セラピューティクス インク． |
融合タンパク質を用いたｔｃｒの再プログラミングのための組成物及び方法
|
|
WO2018119298A1
(en)
*
|
2016-12-21 |
2018-06-28 |
TCR2 Therapeutics Inc. |
Engineered t cells for the treatment of cancer
|
|
WO2018147805A1
(en)
*
|
2017-02-08 |
2018-08-16 |
Agency For Science, Technology And Research |
Gamma delta t cells and a method of augmenting the tumoricidal activity of the same
|
|
AU2018234827B2
(en)
|
2017-03-15 |
2024-04-04 |
Orca Biosystems Inc. |
Compositions and methods for hematopoietic stem cell transplants
|
|
GB201707048D0
(en)
*
|
2017-05-03 |
2017-06-14 |
King S College London |
Expansion of gamma delta cells, compositions, and methods of use thereof
|
|
US12384830B2
(en)
*
|
2017-06-02 |
2025-08-12 |
Regents Of The University Of Minnesota |
Compositions and methods for improving immunotherapy
|
|
WO2018236986A1
(en)
*
|
2017-06-20 |
2018-12-27 |
The Trustees Of Columbia University In The City Of New York |
Engineered t-cell receptors and methods of their use
|
|
US10806780B2
(en)
|
2017-06-28 |
2020-10-20 |
Regeneron Pharmaceuticals, Inc. |
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
|
|
US20200297871A1
(en)
*
|
2017-09-15 |
2020-09-24 |
King's College London |
Compositions and methods for enhancing gamma delta t cells in the gut
|
|
TWI687227B
(zh)
*
|
2017-10-03 |
2020-03-11 |
生倍科技股份有限公司 |
用於t細胞免疫療法之組合及其用途
|
|
CN109777778B
(zh)
*
|
2017-11-14 |
2023-07-18 |
中国科学院广州生物医药与健康研究院 |
一种基因改造的γδT细胞
|
|
IL274640B1
(en)
|
2017-11-15 |
2025-10-01 |
Adicet Bio Inc |
Methods for selective expansion of delta 3 gamma-delta T-cell populations and preparations thereof
|
|
DE102017127984B4
(de)
|
2017-11-27 |
2019-12-05 |
Immatics US, Inc. |
Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
|
|
CN108129566B
(zh)
*
|
2017-12-31 |
2021-05-11 |
中国科学院武汉病毒研究所 |
靶向间皮素的c-型单域抗体及其制备方法与应用
|
|
US12215154B2
(en)
|
2018-01-19 |
2025-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting γδ T cells with chimeric antigen receptors
|
|
WO2019178463A1
(en)
*
|
2018-03-16 |
2019-09-19 |
H. Lee Moffitt Cancer Center And Research Institute Inc. |
Chimeric antigen receptors with mutated cd28 phosphorylation sites
|
|
GB201804701D0
(en)
|
2018-03-23 |
2018-05-09 |
Gammadelta Therapeutics Ltd |
Lymphocytes expressing heterologous targeting constructs
|
|
JP7055469B2
(ja)
*
|
2018-05-08 |
2022-04-18 |
国立大学法人大阪大学 |
ホモ接合型細胞の作製方法
|
|
CN110577932A
(zh)
*
|
2018-06-07 |
2019-12-17 |
亘喜生物科技（上海）有限公司 |
一种脐带血来源的嵌合抗原受体t细胞
|
|
WO2020018695A1
(en)
*
|
2018-07-18 |
2020-01-23 |
Amgen Inc. |
Chimeric receptors to steap1 and methods of use thereof
|
|
US11987631B2
(en)
*
|
2018-08-01 |
2024-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
|
|
CN108949685B
(zh)
*
|
2018-08-02 |
2022-03-29 |
吉林大学第一医院 |
一种体外诱导扩增高杀伤活性γδT细胞的方法
|
|
US12156888B2
(en)
|
2018-08-07 |
2024-12-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
CAR T-cells for the treatment of bone metastatic cancer
|
|
US20210177903A1
(en)
*
|
2018-08-07 |
2021-06-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Car t-cells for the treatment of bone metastatic cancer
|
|
WO2020029171A1
(zh)
*
|
2018-08-09 |
2020-02-13 |
深圳华大生命科学研究院 |
无内源hla基因背景的抗原递呈细胞系的构建方法、抗原递呈细胞系及其用途
|
|
DK3835415T3
(en)
*
|
2018-08-10 |
2025-01-02 |
Univ Kyoto |
Fremgangsmåde til fremstilling af cd3-positiv celle
|
|
CN110423757B
(zh)
*
|
2018-08-11 |
2021-03-30 |
广东天科雅生物医药科技有限公司 |
一种工程化核酸、t细胞及其应用和产生方法
|
|
CN109161533B
(zh)
*
|
2018-08-28 |
2020-07-24 |
深圳市菲鹏生物制药股份有限公司 |
无血清培养组合物及其应用
|
|
BR112021005184A8
(pt)
|
2018-09-19 |
2022-08-16 |
Lava Therapeutics B V |
Imunoglobulina cd1d de dupla ação
|
|
KR20210087458A
(ko)
*
|
2018-10-01 |
2021-07-12 |
아디셋 바이오, 인크. |
고형 종양 치료를 위한 조작된 및 비-조작된 γδ-T 세포에 관한 조성물 및 방법
|
|
EA202190926A1
(ru)
*
|
2018-10-01 |
2021-06-25 |
Эдисет Био, Инк. |
Композиции и способы в отношении сконструированных и несконструированных t-клеток для лечения гематологических опухолей
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
KR20210093908A
(ko)
|
2018-10-23 |
2021-07-28 |
리제너론 파아마슈티컬스, 인크. |
Ny-eso-1 t 세포 수용체 및 이의 사용 방법
|
|
GB201818243D0
(en)
|
2018-11-08 |
2018-12-26 |
Gammadelta Therapeutics Ltd |
Methods for isolating and expanding cells
|
|
US20220218747A1
(en)
|
2018-12-03 |
2022-07-14 |
Adicet Bio, Inc. |
Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof
|
|
CN111544585B
(zh)
*
|
2019-02-11 |
2024-12-27 |
北京卡替医疗技术有限公司 |
一种可助推免疫细胞在体内扩增的佐剂
|
|
JP6884450B2
(ja)
*
|
2019-02-14 |
2021-06-09 |
学校法人獨協学園獨協医科大学 |
Ｔ細胞ワクチン
|
|
WO2020172177A1
(en)
*
|
2019-02-18 |
2020-08-27 |
Memorial Sloan-Kettering Cancer Center |
Combinations of multiple chimeric antigen receptors for immunotherapy
|
|
CA3130442A1
(en)
*
|
2019-02-24 |
2020-08-27 |
Gamida Cell Ltd. |
Method of homing and retention of gammadelta t cells for generating cell compositions for use in therapy
|
|
EP3935151A1
(en)
*
|
2019-03-08 |
2022-01-12 |
Klinikum der Universität München |
Ccr8 expressing lymphocytes for targeted tumor therapy
|
|
CN109758590B
(zh)
*
|
2019-03-28 |
2022-02-11 |
广东工业大学 |
一种用于筛选人前列腺癌肿瘤抗原表位肽的方法
|
|
JP7668226B2
(ja)
*
|
2019-03-30 |
2025-04-24 |
ビオンテック ユーエス インコーポレイテッド |
Ｔ細胞組成物を調製するための組成物および方法、ならびにそれらの使用
|
|
WO2020214957A1
(en)
|
2019-04-19 |
2020-10-22 |
Tcrcure Biopharma Corp. |
Anti-pd-1 antibodies and uses thereof
|
|
JP2022529380A
(ja)
*
|
2019-04-26 |
2022-06-21 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
キメラ抗原受容体構築物およびｃａｒ－ｔ細胞におけるそれらの使用
|
|
KR20220017892A
(ko)
*
|
2019-05-08 |
2022-02-14 |
얀센 바이오테크 인코포레이티드 |
T세포 매개 면역의 조절을 위한 물질 및 방법
|
|
AU2020314956A1
(en)
*
|
2019-07-17 |
2022-03-03 |
Case Western Reserve University |
Long lived T cells for treating HIV infection
|
|
WO2021016652A1
(en)
*
|
2019-07-29 |
2021-02-04 |
The University Of Melbourne |
METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS
|
|
BR112022002837A2
(pt)
*
|
2019-08-16 |
2022-05-10 |
Gammadelta Therapeutics Ltd |
Anticorpo anti-vd1 ou fragmento do mesmo, anticorpo multiespecífico isolado ou fragmento do mesmo, anticorpo humano e anticorpo multiespecífico isolado humano ou fragmento do mesmo
|
|
CN114555785B
(zh)
*
|
2019-10-17 |
2024-12-06 |
香港大学 |
制备v-t细胞衍生的外泌体以治疗epstein-barr病毒相关癌症的方法
|
|
MX2022005033A
(es)
|
2019-10-31 |
2022-09-09 |
Morphosys Ag |
Terapia combinada antitumoral que comprende un anticuerpo anti grupo de diferenciación 19 (cd19) y linfocitos t gamma delta.
|
|
EP4072567A4
(en)
*
|
2019-12-03 |
2024-03-27 |
Adicet Therapeutics, Inc. |
METHOD FOR EXPANSION OF GAMMA DELTA T CELL POPULATIONS USING MULTIVALENT AGENTS AND COMPOSITIONS THEREOF
|
|
KR20220131956A
(ko)
|
2020-01-24 |
2022-09-29 |
리제너론 파아마슈티컬스, 인크. |
흑색종에서 우선적으로 발현되는 항원(prame) t 세포 수용체 및 이의 사용 방법
|
|
WO2021176373A1
(en)
*
|
2020-03-03 |
2021-09-10 |
Janssen Biotech, Inc. |
ꝩδ T CELLS AND USES THEREOF
|
|
CN115768879A
(zh)
|
2020-04-28 |
2023-03-07 |
莱尔免疫制药公司 |
用于培养细胞的方法
|
|
EP4189074A4
(en)
*
|
2020-06-22 |
2025-01-15 |
Nanjing Legend Biotech Co., Ltd. |
GENETICALLY MODIFIED GAMMA DELTA T CELLS FOR IMMUNOTHERAPY
|
|
MX2023000448A
(es)
|
2020-07-08 |
2023-04-20 |
Lava Therapeutics N V |
Anticuerpos que se unen a antígeno de membrana específico de la próstata (psma) y receptores de celulas t gamma-delta.
|
|
CN115975943A
(zh)
*
|
2020-07-14 |
2023-04-18 |
广州泛恩生物科技有限公司 |
基于acp5阳性t细胞的用于杀伤肿瘤的tcr-t细胞及其制备方法和应用
|
|
JP2024507735A
(ja)
*
|
2021-02-08 |
2024-02-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ブチロフィリンサブファミリー３メンバーａ１（ｂｔｎ３ａ１、ｃｄ２７７）の制御
|
|
GB202105113D0
(en)
*
|
2021-04-09 |
2021-05-26 |
Gammadelta Therapeutics Ltd |
Novel method
|
|
WO2023069322A1
(en)
*
|
2021-10-20 |
2023-04-27 |
University Of Pittsburgh – Of The Commonwealth System Of Higher Education |
Methods and materials for expanding tumor infiltrating gamma-delta t cells
|
|
WO2023092119A2
(en)
|
2021-11-22 |
2023-05-25 |
Ludwig Institute For Cancer Research Ltd |
Methods for predicting responsiveness to a cancer therapy
|
|
CA3240081A1
(en)
*
|
2021-12-05 |
2023-06-08 |
Blake AFTAB |
Treatment of b cell malignancies
|
|
KR20230105166A
(ko)
|
2022-01-03 |
2023-07-11 |
주식회사 이뮤노맥스 |
감마-델타 t 세포의 증식 배양 방법
|
|
CN114149978B
(zh)
*
|
2022-02-09 |
2022-04-26 |
深圳博雅感知药业有限公司 |
制备car-t细胞的方法
|
|
JP2025506506A
(ja)
|
2022-02-16 |
2025-03-11 |
プリオセラ エスエーエス |
Ｓ１ｐ受容体モジュレーターと組み合わせたｃａｒ細胞を用いた処置方法
|
|
GB202204926D0
(en)
|
2022-04-04 |
2022-05-18 |
Gammadelta Therapeutics Ltd |
Method for expanding gammadelta T cells
|
|
WO2023242434A1
(en)
*
|
2022-06-17 |
2023-12-21 |
Gadeta B.V. |
Modified immune cells
|
|
CN115624618A
(zh)
*
|
2022-09-16 |
2023-01-20 |
深圳善乐生物科技有限公司 |
一种HPV多肽抗原负载γδT细胞在HPV阳性宫颈癌免疫治疗中的应用
|
|
AU2023372375A1
(en)
|
2022-10-31 |
2025-04-24 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating cancer with a combination of adoptive cell therapy and a targeted immunocytokine
|
|
AU2024253044A1
(en)
|
2023-04-07 |
2025-10-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating cancer with a lymphotoxin beta receptor agonist
|
|
WO2024243511A1
(en)
|
2023-05-25 |
2024-11-28 |
Regeneron Pharmaceuticals, Inc. |
T cell receptors that bind presented hpv16-, mart1-, cmv-, ebv-, or influenza- peptides
|
|
US12221483B1
(en)
*
|
2024-01-30 |
2025-02-11 |
China Medical University Hospital |
Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
|
|
WO2025165915A1
(en)
*
|
2024-01-31 |
2025-08-07 |
Adicet Therapeutics, Inc. |
Compositions and methods for enhancing engineered t cell therapies
|
|
WO2025229538A1
(en)
*
|
2024-05-01 |
2025-11-06 |
Janssen Biotech, Inc. |
Materials, methods, and systems for cellular expansion of gamma delta t-cells
|